A practical review of diabetes mellitus type 2 treatment in primary care

Rom J Intern Med. 2022 Mar 17;60(1):14-23. doi: 10.2478/rjim-2021-0031. Print 2022 Mar 1.

Abstract

The treatment of diabetes mellitus type 2 (DM2) is becoming more complex as new medications are approved. Primary care providers must maintain their medical knowledge on emerging medications for best patient care. This review simplifies the non-insulin treatments of diabetes with an emphasis on the cardio-renal protectants, sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1).

Keywords: diabetes mellitus type 2; glucagon-like peptide 1 receptor agonists; sodium-glucose cotransporter 2.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucagon-Like Peptide-1 Receptor / agonists
  • Glucagon-Like Peptide-1 Receptor / therapeutic use
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Primary Health Care
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors